VEGFD and neoplasm: By depletion of VEGFR-3+ TAM with clodronate liposomes, Yang et al. were able to obtain a considerable reduction (>80%) in the secretion of VEGF-C and VEGF-D in the tumor mass and also a significant reduction in LVD (Yang et al., 2011).